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Research in the field of adult neurogenesis has seen substantial progress over recent years. Here we discuss
some of the major focus areas for future investigation: neural stem cell heterogeneity, the role of latent stem
cells, and the extent of neurogenesis in the adult human brain.New neurons are supplied throughout life
in most mammals in two regions of the
brain: the dentate gyrus of the hippo-
campus, by locally residing neural stem
cells, and the olfactory bulb, by neural
stem cells present in the lateral ventricle
wall. The new neurons confer plasticity
to the circuitry and increasing evidence
has established a role for adult neuro-
genesis in specific brain functions. The
discovery of neural stem cells and neuro-
genesis in the adult mammalian central
nervous system changed our view of the
plasticity and function of the brain and
spurred enthusiasm for trying to harness
their regenerative potential in new thera-
pies for conditions such as depression,
stroke, spinal cord injury, and Parkinson’s
disease. Our understanding of neural
stem cells has increased dramatically
over the past few years, but there are still
many major gaps, some of which are the
focus of our discussion here.
Neural Stem Cell Heterogeneity
Stem cells are notoriously difficult to iden-
tify, and we have witnessed a gradual
homing in on bona fide stem cells in
many tissues. This progress has been
accompanied by a realization that stem
cell populations are often heterogeneous
within a tissue and that several distinct
stem cells for the same lineage can
coexist. For example, in the skin, intestine,
and hematopoietic system, there are stem
cells that may be in different states of
activity or dormancy or may have different
roles in homeostasis and regeneration.
It will be necessary todevelop adetailed
characterization of the full repertoire of
neurogenic cells in the adult brain to
understand the process of adult neuro-
genesis and to potentially modulate it in
therapeutic strategies. In most studies,
the properties of neural stem cells are
interrogated at a population level ratherthan at the clonal level, resulting in the
analysis of potentially mixed populations,
making it difficult to detect heterogeneity
(Figure 1). Nevertheless, it is already
clear that heterogeneity does exist. For
example, in the hippocampus, there are
at least two morphologically distinguish-
able types of astrocytes that give rise to
neurons, radial and horizontal, but their
lineage relationship is still subject of
debate. There is also conflicting evidence
about whether hippocampal astrocytes
are self-renewing or exhausted during
the process of generating new neurons
(Bonaguidi et al., 2011; Encinas et al.,
2011). These apparently contradictory
results might reflect the coexistence
of several stem cell populations with
different properties. In the ventricle wall
there are indications that astrocytes may
have different activity states marked by
EGFR expression. In several organs, there
are indications that progenitor cells may
be able to revert to a stem cell state, and
it has been suggested that EGF may
induce dedifferentiation of transit ampli-
fying cells in the neural lineage to stem
cells. Moreover, neural stem cells located
at different positions along the ventricle
wall and rostral migratory stream give
rise to different repertoires of olfactory
bulb neurons (Lledo et al., 2008).
Detecting heterogeneity within a popu-
lation is virtually impossible without using
clonal labeling or fate mapping strategies
to mark distinct subpopulations. Thus,
although there are clear indications of
neural stem cell heterogeneity and we
have already learned about some aspects
of it using such approaches, it seems
likely that there is muchmore diversity still
to discover. How do we identify and
characterize subpopulations that we do
not even know exist? Neuroscience may
perhaps be able to learn from genetic
fate mapping strategies used in otherCell Stem Cellorgans, which have been extremely help-
ful in identifying diversity. As our marker
and genetic reagent tool boxes grow, we
are likely to continue finding new features
of neural stem cells.
Latent Neural Stem Cell Activity
It became clear during early studies of
neural stem cells not only that cells with
in vitro neural stem cell properties are
found in neurogenic niches, but also that
they are in fact present in most major
subdivisions of the adult central nervous
system. Moreover, injury endows addi-
tional cells with in vitro neural stem cell
properties (Barnabe´-Heider et al., 2010;
Buffo et al., 2008). Thus, in addition to the
neural stem cells that are responsible for
physiological adult neurogenesis, there
are other cells that may have similar
potential butare largelydormant (Figure1).
Which are these latent neural stem cells,
what is their in vivo function, and can
they be induced to replace lost cells?
Cortical astrocytes gain in vitro neural
stem cell properties after injury (Buffo
et al., 2008). However, there is no
evidence that they produce cells other
than astrocytes outside the neurogenic
niches in vivo, and their main function
after injury may be to participate in the
formation of a glial scar. We do not know
today what distinguishes a neurogenic
astrocytic stem cell from an astrocyte
with latent stem cell or neurogenic poten-
tial. It is probably in part regulated cell
intrinsically, as neurogenic and nonneuro-
genic astrocytes are intermingled in the
neurogenic niches. Spinal cord ependy-
mal cells have in vitro neural stem cell
properties but are largely dormant and
do not generate other cell types in vivo
in the absence of injury (Figure 1). In
response to injury, their proliferation is
dramatically increased, a much larger
number of them display in vitro neural10, June 14, 2012 ª2012 Elsevier Inc. 657
Figure 1. Actual and Possible Neural Stem Cells
Active neural stem cell niches in the mouse dentate gyrus and lateral ventricle (LV) wall, showing astrocyte-like stem cells labeled for glial fibrillary acidic protein
(GFAP) and the SRY-BOX 2 (Sox2) transcription factor, and neuroblasts expressing doublecortin (DCX) (Bonaguidi et al., 2011; Lledo et al., 2008). Latent neural
stem cell niches in the adult spinal cord and cortex showing ependymal cells lining the central canal (CC) labeled for Sox2 but negative for GFAP and parenchymal
astrocytes expressing GFAP and Sox2, respectively (Barnabe´-Heider et al., 2010; Buffo et al., 2008). Scale bar represents 20 mm.
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the main source of new glial cells in the
injured spinal cord (Barnabe´-Heider
et al., 2010). Forebrain ependymal cells
lining the lateral walls are completely
quiescent but can give rise to astrocytes
and neuroblasts in response to stroke.
However, unlike spinal cord ependymal
cells, they do not self-renew, and instead
are consumed in the process of gener-
ating progeny (Carle´n et al., 2009). Thus,
among these heterogeneous latent cells,
so far there is only evidence that the cells
in the neurogenic lateral ventricle wall
niche can generate neuronal lineage cells
in vivo.
Heterotopic transplantation experi-
ments have indicated that the neurogenic
capacity of adult neural stemcells is deter-
mined, at least in part, by their extracel-
lular molecular environment. Unleashing
latent neurogenic potential outside of
normal neurogenic regions is a tantalizing
proposition, but a major limiting factorFigure 2. Neuroblast Kinetics in the Human Brain
Quantification of neuroblasts in the human subventricular zone
(SVZ) and dentate gyrus at different ages based on doublecor-
tin (DCX) expression. Note the logarithmic scale on the y axis.
Data are from Knoth et al. (2010) and Sanai et al. (2011).may be the capacity of new neurons
to integrate in regions outside of
areas that are normally neurogenic.
In lower vertebrates, such as the
newt, neurons can be regenerated
after lesions by latent stem/progen-
itor cells even in normally nonneuro-
genic regions. Understanding the
regenerative mechanisms in lower
vertebrates could potentially shed
light on, and suggest ways to over-
come, the restrictions that exist in
the mammalian nervous system.
Although most attention is
focused on potential therapeutic
strategies that involve the genera-
tion of new neurons, it is also attrac-
tive to consider the possibility of658 Cell Stem Cell 10, June 14, 2012 ª2012influencing gliogenesis. Glial cells support
neuronal function in many ways, and in
some neural stem cell transplantation
experiments the beneficial effect on
functional recovery is mediated by glial
differentiation, rather than by neurons.
Demyelination in multiple sclerosis and
many other types of injuries results in
neuronal malfunction and, over time,
neuronal degeneration if the axon is not
remyelinated. Endogenous neural stem
cells give rise mainly to scar-forming
astrocytes and few remyelinating oligo-
dendrocytes after spinal cord injury
(Barnabe´-Heider et al., 2010). It is ap-
pealing to look at influencing gliogenesis,
for example, to promote differentiation to
remyelinating oligodendrocytes at the
expense of scar forming astrocytes.
Understanding and Mending
the Human Brain
From the outset, enthusiasm in the neural
stem cell field was buoyed by the pros-Elsevier Inc.pect of developing new therapies for
neurological and psychiatric diseases.
Neuronal replacement by cell transplanta-
tion has been explored intensively over
recent years, and cell replacement from
endogenous sources is an attractive alter-
native. However, the extent to which
findings made in the mouse and other
mammals will translate to human settings
still remains largely unclear. It will there-
fore be important to establish the extent
of neurogenesis in the adult human
brain in normal and pathological situa-
tions to understand whether this process
could contribute to normal brain function
and whether alterations in it may be
related to pathology. A seminal study by
Eriksson, Gage, and colleagues demon-
strated BrdU labeling in hippocampal
neurons in a group of cancer patients
that received the labeled nucleotide for
disease staging purposes, establishing
the presence of adult neurogenesis in
humans (Eriksson et al., 1998). However,this analysis did not allow quantita-
tive assessment of the extent of
neurogenesis or insights as to
whether the process may be
affected by pathology.
Indications of the extent of neuro-
genesis can be inferred from the
number of neuroblasts in a given
region. The number of cells with
neuroblast markers drops precipi-
tously in the first few months after
birth in humans, with similar kinetics
and to a similar extent in the hippo-
campus and subventricular zone
(Figure 2), leaving only miniscule
apparent numbers of neuroblasts
after the first year (Knoth et al.,
2010; Sanai et al., 2011). These low
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genesis is unlikely to be functionally
relevant in the adult human brain.
However, one should interpret these
data with some caution, as they could
represent either an overestimate of the
number of functionally active neural
stem cells or an underestimate if there
are other cells that do not express the
tested markers. Moreover, computational
modeling has suggested that even small
numbers of new neurons can have
a significant influence on overall circuitry.
In addition, even if neurogenesis in
adult humans is normally very limited,
it could still be activated in pathological
situations. Retrospective 14C birth dating
allows a direct measurement of the age
of a cell population, and this has
established that there is minimal, if any,
adult olfactory bulb neurogenesis in
humans (Bergmann et al., 2012). One
may argue that humans depend to a small
degree on olfaction, and that hippo-
campal neurogenesis may be more rele-
vant, but the similar dynamics of neuro-
blast generation in both neurogenic
niches in humans raises the question ofwhether there may be any functionally
relevant degree of neurogenesis in the
hippocampus.
Adult neurogenesis has advanced from
a controversial suggestion to having
established roles in brain function in
rodents. As we are delineating the normal
extent and understanding the mecha-
nisms regulating this process, one of the
main goals for the future remains to
assess whether it is possible to influence
neural stem cells to replace cells in
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